IFHR is in position of strength with their extremely low float of 8.8 Million and no dilution - any major push can drive this to ‘blue’ sky levels.
IFHR last traded at $0.12 and pushing 26.31% higher – we are well on our way to monster gains and on high news watch for updates from the company.
IFHR has been identified as a reverse merger candidate and preparing Audited financial statements for uplisting.
- Extremely small float and outstanding – only 8.8M float!
- No Dilution
- Reverse Merger imminent as communicated by today’s Press Release
- Annual Filings posted to otcmarkets.com in Audit Financial Style in preparation for uplisting.
Our alert on CBIS is showing huge potential for solid gains.
CBIS recently announced that “A&E Begins Filming An 8-episode Documentary With Cannabis Science’s Newly Appointed Director of Horticulture Bret Bogue; Focused On Bret Bogue, World Renowned Medical Cannabis Cultivator”
We look forward to this Documentary that will give huge exposure to CBIS and monster long term gains!
About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The second formulations will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. Eventually, all Americans will have access to a safe and effective FDA approved medicine regardless of which state they live in. To maintain that marijuana is a dangerous, addictive drug with no medical value is scientifically absurd. Cannabis medicines, with no effective lethal dose, are far safer than aspirin, acetaminophen, and most other OTC drugs that kill thousands of Americans every year.
The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
Follow us on twitter at http://www.twitter.com/ourhotstockpick and become the first to see what our next HOT Stock Pick will be.
Ourhotstockpicks.com profiles are not a solicitation or recommendation to buy, sell or hold securities and is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. Ourhotstockpicks received fifty thousand for 1 week profile of IFHR and may be buyers of features in the open market. Click here to view the full disclaimer